RXRX R&D Expenses
Recursion Pharmaceuticals Inc Clas · R&D Expenses
RXRX R&D Expenses
Latest reported$381.91Mperiod ending
RXRX R&D Expenses ($45.81M → $381.91M)
Annual R&D Expenses
High-resolution chart · PNG
RXRX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 425,270,000 | |
| 314,421,000 | |
| 241,226,000 | |
| 155,696,000 | |
| 135,271,000 | |
| 63,319,000 | |
| 45,809,000 |